A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

By Coleman R.E.   Houston S.   Purohit O.P.   Rubens R.D.   Kandra A.   Ford J.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 820-824

Elsevier

Access to resources Recommend Favorite

The impact of pamidronate on inpatient and outpatient services among metastatic breast cancer patients

By Beusterien Kathleen   Hill Michelle   Ackerman Stacey   Zacker Christopher  

Supportive Care in Cancer, Vol. 9, Iss. 3, 2001-05 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite

Does Supportive Pamidronate Treatment Prevent or Delay the First Manifestation of Bone Metastases in Breast Cancer Patients?

By van Holten-Verzantvoort A.T.M.   Hermans J.   Beex L.V.A.M.   Blijham G.   Cleton F.J.   van Eck-Smit B.C.F.   Sleeboom H.P.   Papapoulos S.E.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Locally advanced primary breast cancer - medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy

By Tan S.M.   Cheung K.L.   Willsher P.C.   Blamey R.W.   Chan S.Y.   Robertson J.F.R.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2331-2338

Elsevier

Access to resources Recommend Favorite

Pamidronate Infusions as Single-agent Therapy for Bone Metastases: A Phase II Trial in Patients with Breast Cancer

By Tyrrell C.T.   Bruning P.F.   May-Levin F.   Rose C.   Mauriac L.   Soukop M.   Ford J.M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1976-1980

Elsevier

Access to resources Recommend Favorite